Innovative Automated Insulin Delivery System for Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 307 participants.

Also called NCT06853990

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 307 participants (enrolled count) (from the registry)
Sponsor
Deka Research and Development (from the registry)
Registry
  • NCT NCT06853990
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06853990. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-14 (actual); primary completion 2026-02-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Innovative Automated Insulin Delivery System for Type 2 Diabetes
Acronym
twiist-T2D
Condition
Insulin Treated Type 2 Diabetes Mellitus
Intervention (Device)
twiist insulin delivery system
Lead sponsor
Deka Research and Development (class: industry)
Collaborator
Sequel Med Tech (class: not stated)

Record details

Record id
cardio:ct-nct06853990
Content hash
1cc7fb1e674103c84f4571ee4575f2023a915acadd1698094293064a3a764b8f